Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
20 Oct 2026, 12:00 pm4d left
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Published by the portal on this tender, for queries and grievance redressal.
MS ECHS RE URG 05 2026 27
10014877
GEM/2026/B/8143146
Two Packet Bid
Tab Lorazepam 2 mg
Bikaner, Rajasthan
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹31
₹2 L
70%
Exempted
Yes
10 Oct 2026
10 Oct 2026
21 Oct 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Tab Lorazepam 2 mg | 3,900 | No | Bikaner | 15 |
| 2 | Tab Mefenamic acid 500 mg | 3,300 | No | Bikaner | 15 |
| 3 | Tab Melatonin 3 mg | 1,380 | No | Bikaner | 15 |
| 4 | Tab Mesalamine 400 mg | 1,980 | No | Bikaner | 15 |
| 5 | Tab Methimazole 5 mg | 2,100 | No | Bikaner | 15 |
| 6 | Tab Methotraxate 15 mg | 3,180 | No | Bikaner | 15 |
| 7 | Tab Methotraxate 2 point 5 mg | 3,900 | No | Bikaner | 15 |
| 8 | Tab Metaclopramide 10 mg | 2,850 | No | Bikaner | 15 |
| 9 | Tab Mirtazapine 10 mg | 1,800 | No | Bikaner | 15 |
| 10 | Tab Nebivilol 5 mg | 2,400 | No | Bikaner | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_10014877.pdf
GEM_BID • 0.15 MB
gemartps_re05_2026-10-10-11-33-32_56cc0b7a21f81dbe1060352b22332ad1.pdf
BOQ • 0.32 MB
boq_item_sample_file_2026-10-10-11-33-32_dddc44502f0cc41b574d50fe6adeb9a1.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .